Suppr超能文献

非洲帕金森病治疗方法和服务的可及性:一项全大陆范围的调查。

Availability of Therapies and Services for Parkinson's Disease in Africa: A Continent-Wide Survey.

机构信息

Department of Neurology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Department of Neurology, Black Lion Specialized Hospital, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.

出版信息

Mov Disord. 2021 Oct;36(10):2393-2407. doi: 10.1002/mds.28669. Epub 2021 Jun 3.

Abstract

BACKGROUND

The growing burden of Parkinson's disease (PD) in Africa necessitates the identification of available therapies and services to improve patient care.

OBJECTIVE

To investigate the availability, affordability, frequency of usage, and insurance coverage of PD therapies (pharmacological, surgical, physical, and speech therapies) and services including specialized clinics, specialists, and nurses across Africa.

METHODS

A comprehensive web-based survey was constructed and distributed to neurologists/physicians with a special interest in PD across Africa. The survey instrument includes components that address availability, affordability, frequency of use, and insurance coverage of different therapies and services.

RESULTS

Responses were received from 28 (of 43 contacted) countries. Levodopa-based oral preparations were always available in 13 countries (46.4%) with variable affordability and "partial or no" insurance coverage in 60% of countries. Bromocriptine was the most available (50%) and affordable ergot dopamine agonists (DA), whereas non-ergot DA was always available in only six countries (21.4%). Trihexyphenidyl was the most available and affordable anticholinergic drug (46.4%). Tricyclic antidepressants and selective serotonin reuptake inhibitors were available in most countries (89.3% and 85.7% respectively), with variable affordability. Quetiapine and clozapine were less available. Specialized clinics and nurses were available in 25% and 7.1% of countries surveyed, respectively. Other services were largely unavailable in the countries surveyed.

CONCLUSION

PD-specific therapies and services are largely unavailable and unaffordable in most African countries. The data provide a platform for organizing strategies to initiate or scale up existing services and drive policies aimed at improving access to care and tailoring education programs in Africa. © 2021 International Parkinson and Movement Disorder Society.

摘要

背景

帕金森病(PD)在非洲的负担日益加重,因此需要确定现有的治疗方法和服务,以改善患者的护理。

目的

调查非洲 PD 治疗方法(药物治疗、手术治疗、物理治疗和言语治疗)和服务(包括专门诊所、专家和护士)的可及性、可负担性、使用频率和保险覆盖范围。

方法

我们构建了一个全面的基于网络的调查,并分发给对 PD 有特殊兴趣的非洲神经科医生/医生。该调查工具包括针对不同治疗方法和服务的可及性、可负担性、使用频率和保险覆盖范围的组件。

结果

收到了来自 28 个(接触的 43 个中的 28 个)国家的回复。左旋多巴口服制剂在 13 个国家(46.4%)始终可用,在 60%的国家具有可负担性和“部分或无”保险覆盖范围。溴隐亭是最可用(50%)和负担得起的麦角多巴胺激动剂(DA),而非麦角 DA 仅在六个国家(21.4%)始终可用。三己酚是最可用和负担得起的抗胆碱能药物(46.4%)。三环类抗抑郁药和选择性 5-羟色胺再摄取抑制剂在大多数国家(分别为 89.3%和 85.7%)均可用,但可负担性不同。喹硫平和氯氮平的可用性较低。在接受调查的国家中,有 25%的国家提供专门诊所,7.1%的国家提供护士。其他服务在调查的国家中基本不可用。

结论

在大多数非洲国家,PD 特定的治疗方法和服务基本上无法获得且负担不起。这些数据为制定战略提供了平台,以启动或扩大现有服务,并推动旨在改善获得护理机会和调整非洲教育计划的政策。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验